Valuation: Square Pharmaceuticals PLC.

Market Cap 192B 1.55B 1.38B 1.26B 1.15B 2.16B 146B 2.21B 15.05B 6.04B 77.44B 5.81B 5.68B 245B P/E 2026 *
7.32x
P/E 2027 * 6.52x
Enterprise Value 192B 1.55B 1.38B 1.26B 1.15B 2.16B 146B 2.21B 15.05B 6.04B 77.44B 5.81B 5.68B 245B EV / Sales 2026 *
2.26x
EV / Sales 2027 * 2.03x
Free-Float
55.9%
Yield 2026 *
-
Yield 2027 * -
1 day+0.46%
1 week-1.01%
Current month-0.87%
1 month-0.78%
3 months-1.59%
6 months+2.51%
Current year+9.06%
1 week 213.8
Extreme 213.8
219.3
1 month 213.8
Extreme 213.8
220.7
Current year 198.1
Extreme 198.1
236
1 year 198
Extreme 198
236
3 years 197.2
Extreme 197.2
249.8
5 years 197.2
Extreme 197.2
249.8
10 years 149.05
Extreme 149.047619
278.67
Manager TitleAgeSince
Chief Executive Officer - 31/12/1994
Director of Finance/CFO - -
Compliance Officer - -
Director TitleAgeSince
Chairman - 31/12/2011
Director/Board Member - 31/12/1979
Director/Board Member - 31/12/2006
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%-1.01%+1.93%+2.56% 1.53B
+0.61%+10.62%+58.16%+149.73% 1,255B
+3.81%+2.82%+48.35%+82.58% 641B
+3.09%+2.95%+39.10%+108.48% 505B
+1.25%-0.78%+52.56%+66.87% 381B
+3.93%+6.02%+82.28%+45.44% 357B
+2.10%+4.26%+34.93%+61.10% 303B
+1.92%+9.37%+13.43%+36.55% 286B
+3.73%+6.82%+61.48%+77.31% 249B
+4.19%+9.68%+42.96%+113.85% 208B
Average +1.65%+2.57%+43.52%+74.45% 418.68B
Weighted average by Cap. +1.14%+3.90%+50.59%+97.75%

Financials

2026 *2027 *
Net sales 85.11B 686M 611M 560M 509M 959M 64.92B 980M 6.67B 2.68B 34.33B 2.57B 2.52B 109B 94.79B 764M 680M 624M 567M 1.07B 72.3B 1.09B 7.43B 2.98B 38.23B 2.87B 2.81B 121B
Net income 26.6B 214M 191M 175M 159M 300M 20.29B 306M 2.09B 837M 10.73B 805M 788M 33.97B 29.57B 238M 212M 195M 177M 333M 22.56B 340M 2.32B 930M 11.93B 895M 875M 37.77B
Net Debt - -
Projected Income Statement - Annual - Square Pharmaceuticals PLC.
Logo Square Pharmaceuticals PLC.
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical manufacturer and exporter. Its core business activities include the manufacture and distribution of generic pharmaceutical products, basic chemical products, and animal health products. The Company operates in one segment: the business of developing, manufacturing, and marketing drugs for healthcare for all living species. It is also involved in the distribution of crop care products. The Company offers its products in several categories, including products listed by trade name, by therapeutic class, and by generic name. In addition to conventional pharmaceuticals, it also offers products under the Herbal & Nutraceuticals category, as well as AgroVet & Pesticides, which cover veterinary and agricultural chemical products. The Company’s manufacturing facilities are located in Pabna and Dhaka, Bangladesh. Its subsidiaries include Square Lifesciences Ltd., Square Pharmaceuticals Kenya EPZ Ltd., and Samson Pharma Inc.
Employees
15,937
Date Price Change Volume
04/11/26 BDT 216.60 +0.46% 323,813
03/11/26 BDT 215.60 -0.37% 384,818
02/11/26 BDT 216.40 -0.69% 208,680
01/11/26 BDT 217.90 -0.27% 180,236
29/10/26 BDT 218.50 -0.14% 159,227
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Square Pharmaceuticals PLC.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
216.60BDT
Average target price
352.20BDT
Spread / Average Target
+62.60%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Square Pharmaceuticals PLC.
  1. Stock Market
  2. Stocks
  3. SQURPHARMA Stock